Skip to main content
Premium Trial:

Request an Annual Quote

TriLink Gets SBIR Grant for DNA Ligase Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today said that it has received a Phase II Small Business Innovation Research grant of around $725,000 to continue its studies of DNA ligase.

The San Diego-based firm said that it will use the funds to continue its research on chemically modified components as a means of enhancing ligation fidelity in a variety of applications including SNP detection, proximity ligation, and sequencing by ligation.

TriLink CEO Richard Hogrefe said in a statement that the firm is "confident we will soon offer a number of novel ligation products to compliment our CleanAmp PCR line of products."

TriLink said the latest award is its fourth Phase II grant and will be provided through February 2012.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.